IART News Alert Integra Lifesciences Holdings Corp (IART) 53.68

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Integra Lifesciences Holdings Corp (IART) 53.68 $IART

Integra LifeSciences Hits 52-Week High on Portfolio Strength - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Dec 24, 12:00PM CST
Over the last few months, Integra LifeSciences Holdings Corporation (IART) has launched back-to-back products which we believe will enhance the overall product portfolio and also usher in more profitability for the company.
ZMH: 114.11 (+0.64), JNJ: 104.59 (+0.31), IART: 53.68 (+0.32), SYK: 96.00 (-0.61)

How to Invest Money: This Secret Could Save You Thousands
Brian Stoffel, The Motley Fool - Motley Fool - Mon Dec 22, 8:00AM CST
The secret of how to invest money is so simple these kids could get it right. Photo: Flickr user Mike King. Here at The Motley Fool, we try to avoid giving blanket advice on investing, because there are as many paths to financial independence as...
BEBE: 2.48 (-0.15), BIIB: 340.89 (+5.13), PSUN: 2.07 (+0.05), RECN: 16.41 (+0.22), VALU: 16.26 (+0.68), GRMN: 53.86 (+0.50), QSII: 15.73 (+0.23), AMED: 28.97 (-0.08), UMPQ: 17.28 (+0.06), YHOO: 50.65 (+0.63), RCL: 82.36 (+0.16), IART: 53.68 (+0.32), ATLC: 2.50 (+0.01), AEO: 13.53 (+0.02), ARMH: 46.80 (+0.46), CEB: 73.03 (+0.23), GPS: 41.46 (+0.09)

Integra Lifesciences Up on Launch of Bilayer Skin Product - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Dec 19, 12:40PM CST
This latest single-use skin product of Integra (IART) is at present the only pre-meshed bilayer matrix that has been approved by the FDA to treat patients with third-degree burns and the subsequent scar contracture.
BIIB: 340.89 (+5.13), IART: 53.68 (+0.32), ANIP: 55.24 (+1.79), AFFX: 9.80 (+0.05)

Integra LifeSciences Launches Integra(R) Meshed Dermal Regeneration Template
GlobeNewswire - Wed Dec 17, 7:30AM CST
Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the expansion of its skin and wound product line with the introduction of IntegraMeshed Dermal Regeneration Template. Integra Meshed Dermal Regeneration Template has received Pre-Market Approval (PMA) from the United States Food and Drug Administration (FDA), and expects to begin a full market release in the United States in January 2015. Integra's newest skin product will be featured at the John A. Boswick Burn and Wound Care Symposium, February 14-18, 2015.
IART: 53.68 (+0.32)

Strong And Under The Radar Today: Integra Lifesciences Holdings (IART)
at The Street - Tue Dec 16, 10:44AM CST
Trade-Ideas LLC identified Integra Lifesciences Holdings (IART) as a strong and under the radar candidate
IART: 53.68 (+0.32)

Italy Tissue Engineered - Skin Substitutes Market Outlook to 2020: Key players covered include Organogenesis, Smith & Nephew and Molnlycke Health Care
M2 - Wed Dec 10, 11:34AM CST
Research and Markets (http://www.researchandmarkets.com/research/gzsh2g/italy_tissue) has announced the addition of the "Italy Tissue Engineered - Skin Substitutes Market Outlook to 2020" report to their offering. Our new report, "Italy Tissue Engineered - Skin Substitutes Market Outlook to 2020", provides key market data on the Italy Tissue Engineered - Skin Substitutes market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - Synthetic Skin Substitutes, Biosynthetic Skin Substitutes and Biologic Skin Substitutes (Allograft (Cellular and Acellular) and Xenograft Acellular). The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Tissue Engineered - Skin Substitutes market wherever available. The data in the report is derived from dynamic market forecast models. The publisher uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Key Topics Covered: 1 List of Tables 2 Introduction 3 Tissue Engineered - Skin Substitutes Market, Italy 4 Overview of Key Companies in Italy, Tissue Engineered - Skin Substitutes Market 5 Appendix Companies Mentioned: - Organogenesis, Inc. - Molnlycke Health Care AB - Smith & Nephew Plc - BSN medical GmbH - Integra LifeSciences Holdings Corporation - Kinetic Concepts, Inc. - Covidien plc For more information visit http://www.researchandmarkets.com/research/gz...aly_tissue
SNN: 38.18 (+0.14), IART: 53.68 (+0.32)

Asia-Pacific Tissue Engineered - Skin Substitutes Market Outlook to 2020: Key players covered include Japan Tissue Engineering and Smith & Nephew
M2 - Tue Dec 09, 3:47AM CST
Research and Markets (http://www.researchandmarkets.com/research/ctmnfq/asiapacific) has announced the addition of the "Asia-Pacific Tissue Engineered - Skin Substitutes Market Outlook to 2020" report to their offering. Our new report, "Asia-Pacific Tissue Engineered - Skin Substitutes Market Outlook to 2020", provides key market data on the Asia-Pacific Tissue Engineered - Skin Substitutes market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - Synthetic Skin Substitutes, Biosynthetic Skin Substitutes and Biologic Skin Substitutes (Allograft (Cellular and Acellular) and Xenograft Acellular). The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Tissue Engineered - Skin Substitutes market wherever available. The data in the report is derived from dynamic market forecast models. The publisher uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. Key Topics Covered: 1 List of Tables 2 Introduction 3 Tissue Engineered - Skin Substitutes Market, Asia-Pacific 4 Tissue Engineered - Skin Substitutes Market, Australia 5 Tissue Engineered - Skin Substitutes Market, China 6 Tissue Engineered - Skin Substitutes Market, India 7 Tissue Engineered - Skin Substitutes Market, Japan 8 Tissue Engineered - Skin Substitutes Market, South Korea 9 Overview of Key Companies in Asia-Pacific Tissue Engineered - Skin Substitutes Market 10 Appendix Companies Mentioned: - Japan Tissue Engineering Co., Ltd. - Smith & Nephew Plc - PolyNovo Biomaterials Pty Ltd - Molnlycke Health Care AB - National Tissue Engineering Research Center - L&C Bio - BSN medical GmbH - Covidien plc - Kinetic Concepts, Inc. - CG Bio Inc. - Integra LifeSciences Holdings Corporation - HansBiomed Co., Ltd - Cellumed Co. Ltd For more information visit http://www.researchandmarkets.com/research/ct...siapacific
SNN: 38.18 (+0.14), IART: 53.68 (+0.32)

Symmetry Medical Divests OEM, Surgical Goes Public - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Dec 08, 12:40PM CST
Symmetry Medical Inc. (SMA) recently completed the divestiture of its OEM solutions business unit to Tecomet Inc.
SMA: 9.27 (-0.04), IART: 53.68 (+0.32), MDT: 74.08 (+0.31), CFN: 59.18 (+0.04)

Integra LifeSciences Earnings Review: 14 Days after Announcement Shares Down 7.5% (IART)
Comtex SmarTrend(R) - Mon Nov 17, 3:46PM CST
14 days ago, on November 3rd, 2014, Integra LifeSciences (NASDAQ:IART) reported its earnings. Analysts, on average, expected earnings of $0.74 per share on sales of $233.7 million. Integra LifeSciences actually reported earnings of $0.76 per share on sales of $229.7 million, beating EPS estimates by $0.02 and missing revenue estimates by $3.9 million. Since the company's report, shares of Integra LifeSciences have fallen from $51.49 to $47.64, representing a loss of 7.5% in the past 14 days.
IART: 53.68 (+0.32)

Integra (IART) Strengthens Spinal Implant with Twin Launches - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 17, 2:30PM CST
The latest Interbody and orthobiologic device launches are expected to drive a sequential increase in Integra Lifesciences' (IART) spine sales in the fourth quarter of 2014.
IART: 53.68 (+0.32), ANIP: 55.24 (+1.79), AMAG: 43.02 (+0.90), AFFX: 9.80 (+0.05)

Update: Integra LifeSciences - A Buy After Q3 2014 Earnings
Andy Batts - at Seeking Alpha - Fri Nov 14, 8:23AM CST

IART: 53.68 (+0.32)

Integra LifeSciences wins FDA clearance and controlled market release for Integra Expandable Interbody System in the US
M2 - Fri Nov 14, 6:59AM CST
Medical technology company Integra LifeSciences Holdings (NasdaqGS:IART) said on Thursday that it has received the controlled market release of the Integra Expandable Interbody System in the US.
IART: 53.68 (+0.32)

Integra LifeSciences Announces FDA Clearance and Controlled Market Release of Expandable Interbody System for Spinal Surgery
GlobeNewswire - Thu Nov 13, 7:30AM CST
Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the controlled market release of the Integra Expandable Interbody System, in the United States. The system, which received 510(k) clearance from the United States Food and Drug Administration (FDA) earlier this year, is intended for spinal fusion procedures at one or two contiguous levels (L2-S1) in skeletally mature patients with degenerative disc disease (DDD). The device is intended for use with autogenous bone graft and supplemental fixation and can be used in either posterior or transforaminal lumbar interbody fusion procedures. These procedures are performed to help alleviate pain and nerve compression by fusing and stabilizing adjacent vertebrae in the lower back.
IART: 53.68 (+0.32)

North America Tissue Engineered Skin Substitutes Market Outlook to 2020: Key Players Organogenesis, Inc, Kinetic Concepts, Inc., Shire Plc & Smith & Nephew Plc.
M2 - Thu Nov 13, 3:23AM CST
Research and Markets (http://www.researchandmarkets.com/research/8vj74f/north_america) has announced the addition of the "North America Tissue Engineered - Skin Substitutes Market Outlook to 2020" report to their offering. "North America Tissue Engineered - Skin Substitutes Market Outlook to 2020", provides key market data on the North America Tissue Engineered - Skin Substitutes market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - Synthetic Skin Substitutes, Biosynthetic Skin Substitutes and Biologic Skin Substitutes (Allograft (Cellular and Acellular) and Xenograft Acellular). The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Tissue Engineered - Skin Substitutes market wherever available. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases). Scope - Annualized market revenues (USD million), volume (units) and average prices (in US dollars) data for each of the market segments. Data is provided from 2005 to 2013 and forecast to 2020. - 2013 company shares and distribution shares data for Tissue Engineered - Skin Substitutes market. - Global corporate-level profiles of key companies operating within the North America Tissue Engineered - Skin Substitutes. Companies Mentioned - Organogenesis, Inc. - Shire Plc - Kinetic Concepts, Inc. - Integra LifeSciences Holdings Corporation - Smith & Nephew Plc - Covidien plc - Molnlycke Health Care AB - BSN medical GmbH For more information visit http://www.researchandmarkets.com/research/8v...th_america
SNN: 38.18 (+0.14), IART: 53.68 (+0.32), SHPG: 209.29 (+0.07)

Integra LifeSciences Introduces Integra(R) Pocket Strip and Integra(R) Shaped Strip DBM Implants
GlobeNewswire - Wed Nov 12, 7:54AM CST
Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the limited market release of a new orthobiologic implant. The Demineralized Bone Matrix (DBM) Strip implant is used primarily for posterior lumbar fusion, a surgical procedure intended to promote bone fusion along the posterior elements of the spine. Integra's newest orthobiologic implant, distributed by Integra's subsidiary IsoTis OrthoBiologics, will be featured at the North American Spine Society (NASS) 29 annual meeting, November 12 - 15, 2014 in San Francisco, California.
IART: 53.68 (+0.32)

BRIC Tissue Engineered - Skin Substitutes Market Outlook to 2020: Key Players are Japan Tissue Engineering Co., Ltd. and Smith & Nephew Plc
M2 - Wed Nov 12, 5:32AM CST
Research and Markets (http://www.researchandmarkets.com/research/scwv2r/bric_tissue) has announced the addition of the "BRIC Tissue Engineered - Skin Substitutes Market Outlook to 2020" report to their offering. The report provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Tissue Engineered - Skin Substitutes market wherever available. The data in the report is derived from dynamic market forecast models. The publisher uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Skin Substitutes market. - Synthetic Skin Substitutes - Biosynthetic Skin Substitutes and Biologic - Skin Substitutes (Allograft (Cellular and Acellular) and Xenograft Acellular). Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Tissue Engineered - Skin Substitutes Market, BRIC 4 Tissue Engineered - Skin Substitutes Market, Brazil 5 Tissue Engineered - Skin Substitutes Market, Russia 6 Tissue Engineered - Skin Substitutes Market, India 7 Tissue Engineered - Skin Substitutes Market, China 8 Overview of Key Companies in BRIC Tissue Engineered - Skin Substitutes Market 9 Appendix Companies Mentioned - National Tissue Engineering Research Center - Organogenesis, Inc. - Kinetic Concepts, Inc. - Smith & Nephew Plc - Integra LifeSciences Holdings Corporation - Eucare Pharmaceuticals (P) Ltd. - MedSkin Solutions Dr. Suwelack AG - Molnlycke Health Care AB - BSN medical GmbH - Covidien plc For more information visit http://www.researchandmarkets.com/research/sc...ric_tissue
SNN: 38.18 (+0.14), IART: 53.68 (+0.32)

Integra LifeSciences Holdings (IART) Shares Cross Below 200 DMA
MarketNewsVideo.com - Tue Nov 04, 3:33PM CST
In trading on Tuesday, shares of Integra LifeSciences Holdings Corp crossed below their 200 day moving average of $47.35, changing hands as low as $47.02 per share. Integra LifeSciences Holdings Corp shares are currently trading off about 8.3% on...
IART: 53.68 (+0.32)

Integra Beats Earnings, Sales Up Y/Y, Outlook Lowered - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 10:20AM CST
Integra's (IART) total revenue during the reported quarter increased 7.7% year over year to $229.7 million, but missed the Zacks Consensus Estimate by 1.4%
AGEN: 3.85 (unch), IART: 53.68 (+0.32), AMAG: 43.02 (+0.90), AFFX: 9.80 (+0.05)

Integra LifeSciences Up 7.2% Since SmarTrend Uptrend Call (IART)
Comtex SmarTrend(R) - Tue Nov 04, 9:36AM CST
SmarTrend identified an Uptrend for Integra LifeSciences (NASDAQ:IART) on June 6th, 2014 at $46.21. In approximately 5 months, Integra LifeSciences has returned 7.23% as of today's recent price of $49.54.
IART: 53.68 (+0.32)

Integra LifeSciences Holdings' (IART) CEO Peter Arduini on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Tue Nov 04, 12:06AM CST

IART: 53.68 (+0.32)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Payoneer Gets OCC Nod, but the Finish Line Is Ahead

Updated Category News Views 121

Federal bank paperwork is not usually thrilling, yet Payoneer just found a potentially meaningful lever for its cross-border payments machine. The company received preliminary conditional approval from the Office of the Comptroller of the Currency to form PAYO Digital Bank, a national trust bank intended to support stablecoin services. That is a real regulatory milestone...

Continue Reading
North Richland Hills Bets on Its Visitor Momentum Now

Updated Category News Views 65

A crowded family attraction map is a nice problem for a Texas city to have, and North Richland Hills is trying to turn that pile of assets into a cleaner regional tourism machine. On Nov. 20, 2026, the city introduced “The Place You Never Outgrow,” its first destination-marketing campaign, built with Flat Five Marketing. This is not a stock story in the usual...

Continue Reading
Tigerlily Brings HIV Information to Women’s Health

Updated Category News Views 99

A stubborn information gap is exactly where Tigerlily Foundation is planting its flag. The nonprofit’s new national HIV education and awareness campaign, THE POWER OF U, expands work that began in breast cancer advocacy into another area where women need clear facts, trusted voices, and room to speak without being shamed for needing answers. This is not a story that...

Continue Reading
Jalisco’s Culinary Push Puts Tourism Strategy in Focus

Updated Category News Views 50

A destination sells itself twice: first with a memorable meal, then with a reason to come back. Jalisco’s stated effort to connect the world’s cuisines through The 50 Best Gastronomic Experiences belongs in that second category. It is not merely restaurant chatter. It reads as part of a broader attempt to make the state’s tourism offering feel deeper, more varied...

Continue Reading
Protein Now! Gains Clinician Attention, With Caveats

Updated Category News Views 91

A Small Bottle Has Drawn a Crowd Protein powder tubs have been cluttering kitchens for years; a 3.38-fluid-ounce shot is a cleaner answer to the same daily hassle. NutraBio Labs says more than 800 physicians, nurse practitioners, and physician associates had added PROTEIN NOW! to their individual FrontrowMD patient pages as of November 2026. That earned the product a...

Continue Reading
Fraud0-FouAnalytics Takes Aim at Legacy Ad Verification

Updated Category News Views 95

Digital ad measurement has spent years grading its own homework, and that little arrangement may finally be getting some daylight. fraud0 and FouAnalytics say their expanded partnership will give advertisers impression-level visibility into where ads actually rendered, whether apparent humans engaged with them, and where wasted Google Ads spend might be recoverable. The...

Continue Reading
Rock Gate Buys Aviation Niche Player Blast Deflectors

Updated Category News Views 167

Jet exhaust is not glamorous, but somebody has to keep it from battering everything nearby. Rock Gate Partners’ acquisition of Blast Deflectors, Inc. puts money behind one of those stubbornly unsexy industrial niches where engineering credibility matters far more than a flashy sales pitch. The transaction closed October 16, 2026, and Northborne Partners announced...

Continue Reading
Kinross Lawsuit Puts Round Mountain Claims Under Fire

Updated Category News Views 85

A mine can swallow a rosy forecast faster than any spreadsheet admits. That is the ugly center of the proposed securities class action involving Kinross Gold: not merely that production guidance came down, but the allegation that investors were sold too much confidence before the operational reality at Round Mountain Phase S surfaced. NYSE:KGC dropped from $27.62 on...

Continue Reading
Oatly’s $4.13 Tender Offer Is a Legal Detour, Not a Sale

Updated Category News Views 122

A $4.13 cash offer trading against a $7.17 close is the sort of thing that makes investors squint hard, and Verlinvest is practically waving a flag telling them why. This is not a conventional attempt to buy Oatly Group AB. It is a technical tender offer built to satisfy Swedish takeover rules while Verlinvest buys out its joint-venture partner’s interest in Oatly’s...

Continue Reading
DISA Backs Nursing Education With OADN Foundation Push

Updated Category News Views 79

A nursing workforce does not appear by magic when hospitals need it most; somebody has to help students, instructors, and programs survive the long haul before that first shift. DISA's newly announced partnership with the Organization for Associate Degree Nursing and the OADN Foundation is aimed squarely at that unglamorous, essential stretch of the pipeline. For a sector...

Continue Reading

Top 5 Most Recently Viewed Articles

Molina Healthcare: A Journey of 20 Years of Returns

Updated Category News Views 197

Molina Healthcare's Impressive Investment Journey Molina Healthcare (NASDAQ: MOH) has consistently outperformed the broader market over the last two decades, achieving an impressive annualized return of 12.15%. As a result, this sector leader has garnered significant attention from investors and analysts alike, showcasing its robust performance in the healthcare industry....

Continue Reading
Nokia's Strategic Buyback Program to Enhance Shareholder Value

Updated Category News Views 232

Nokia's Strategic Share Repurchase Initiative Nokia Corporation (NYSE:NOK) has embarked on a significant share repurchase program aimed at mitigating the dilution effects from recent share issuances. This initiative aligns with the company's ongoing commitment to enhancing shareholder value. Recently, Nokia executed the acquisition of 872,093 shares at an average price of...

Continue Reading
Justin Boots Unveils Stylish New Baby Boot Line for First Steps

Updated Category News Views 185

Introducing Mutton Busters Baby Boots by Justin Boots Justin Boots, a name that captures the essence of Western craftsmanship, has launched an exciting new collection for the tiny trendsetters: Mutton Busters. These infant boots are tailored specifically for babies, ensuring comfort, support, and a stylish touch as they take their first steps into the world. Features...

Continue Reading
Waterdrop Inc. Reports Significant Q3 Growth and Innovation

Updated Category News Views 203

Waterdrop Inc. Reports Impressive Financial Results for Q3 Waterdrop Inc. (NYSE: WDH), a prominent technology platform specializing in insurance and healthcare services, recently announced notable financial outcomes for the quarter that ended on September 30, 2025. This report highlights a commendable net operating revenue of RMB 974.9 million, marking a significant...

Continue Reading
Next Technology Holding Inc. Reports Remarkable H1 2025 Growth

Updated Category News Views 150

Next Technology Holding Inc. Delivers Impressive Financial Results for H1 2025 Next Technology Holding Inc. (NASDAQ: NXTT), a leading technology company focused on AI and Bitcoin investments, has released its financial results, showcasing a remarkable surge in performance for the first half of the year. The company, known for its commitment to creating innovative AI...

Continue Reading